{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:20:13Z","timestamp":1770819613792,"version":"3.50.1"},"reference-count":26,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3960\/jslrt.54.67","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T23:13:54Z","timestamp":1403046834000},"page":"67-73","source":"Crossref","is-referenced-by-count":10,"title":["Distinct Global DNA Methylation Status in B-Cell Lymphomas : Immunohistochemical Study of 5-Methylcytosine and 5-Hydroxymethylcytosine"],"prefix":"10.3960","volume":"54","author":[{"given":"Ikuo","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 WHO Classification of Tumours, Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <I>et al<\/I>. (eds): 4th ed, Lyon, IARC, 2008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Dawson MA, Kouzarides T: Cancer epigenetics: from mechanism to therapy. Cell 150:12-27, 2012","DOI":"10.1016\/j.cell.2012.06.013"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Jones PA, Baylin SB: The epigenetics of cancer. Cell 128:683-692, 2007","DOI":"10.1016\/j.cell.2007.01.029"},{"key":"4","unstructured":"4 Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, <I>et al<\/I>.: Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361:1058-1066, 2009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, <I>et al<\/I>.: Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18:553-567, 2010","DOI":"10.1016\/j.ccr.2010.11.015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Quivoron C, Couronn&eacute; L, Della Valle V, Lopez CK, Plo I, <I>et al<\/I>.: TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20:25-38, 2011","DOI":"10.1016\/j.ccr.2011.06.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Matsuda I, Imai Y, Hirota S: Global histone modification profiles are well conserved between normal B lymphocytes and neoplastic counterparts. Pathol Oncol Res 16:447-451, 2010","DOI":"10.1007\/s12253-009-9224-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Choi JH, Li Y, Guo J, Pei L, Rauch TA, <I>et al<\/I>.: Genome-wide DNA methylation maps in follicular lymphoma cells determined by methylation-enriched bisulfate sequencing. PLoS One 5. Pii:e13020, 2010","DOI":"10.1371\/journal.pone.0013020"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Leshchenko VV, Kuo PY, Shaknovich R, Yang DT, Gellen T, <I>et al<\/I>.: Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood 116:1025-1034, 2010","DOI":"10.1182\/blood-2009-12-257485"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Enjuanes A, Fern&agrave;ndez V, Hern&aacute;ndez L, Navarro A, Be&agrave; S, <I>et al<\/I>.: Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma. PLoS One 6:e19736, 2011","DOI":"10.1371\/journal.pone.0019736"},{"key":"11","unstructured":"11 Halld&oacute;rsd&oacute;ttir AM, Kanduri M, Marincevic M, Mansouri L, Isaksson A, <I>et al<\/I>.: Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia. Am J Hematol 87:361-367, 2012"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kreck B, Richter J, Ammerpohl O, Barann M, Esser D, <I>et al<\/I>.: Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing. Leukemia 27:1751-1753, 2013","DOI":"10.1038\/leu.2013.4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Cahill N, Bergh AC, Kanduri M, G&ouml;ransson-Kultima H, Mansouri L, <I>et al<\/I>.: 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 27:150-158, 2013","DOI":"10.1038\/leu.2012.245"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kim K, Doi A, Wen B, Ng K, Zhao R, <I>et al<\/I>.: Epigenetic memory in induced pluripotent stem cells. Nature 467:285-290, 2010","DOI":"10.1038\/nature09342"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, <I>et al<\/I>.: Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28:848-855, 2010","DOI":"10.1038\/nbt.1667"},{"key":"16","unstructured":"16 Chen YH, Hung MC, Li LY: EZH2: a pivotal regulator in controlling cell differentiation. Am J Transl Res 4:364-375, 2012"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Vir&eacute; E, Brenner C, Deplus R, Blanchon L, Fraga M, <I>et al<\/I>.: The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439:871-874, 2006","DOI":"10.1038\/nature04431"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, <I>et al<\/I>.: Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471:189-195, 2011","DOI":"10.1038\/nature09730"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, <I>et al<\/I>.: Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42:181-185, 2010","DOI":"10.1038\/ng.518"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 B&eacute;guelin W, Popovic R, Teater M, Jiang Y, Bunting KL, <I>et al<\/I>.: EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 23:677-692, 2013","DOI":"10.1016\/j.ccr.2013.04.011"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Shaknovich R, Cerchietti L, Tsikitas L, Kormaksson M, De S, <I>et al<\/I>.: DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 118:3559-3569, 2011","DOI":"10.1182\/blood-2011-06-357996"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Daniel JA, Nussenzweig A: The AID-induced DNA damage response in chromatin. Mol Cell 50:309-321, 2013","DOI":"10.1016\/j.molcel.2013.04.017"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Popp C, Dean W, Feng S, Cokus SJ, Andrews S, <I>et al<\/I>.: Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463:1101-1105, 2010","DOI":"10.1038\/nature08829"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Neff T, Armstrong SA: Recent progress toward epigenetic therapies: the example of mixed lineage leukemia. Blood 121:4847-4853, 2013","DOI":"10.1182\/blood-2013-02-474833"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, <I>et al<\/I>.: Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 103:670-676, 2012","DOI":"10.1111\/j.1349-7006.2012.02213.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Lian CG, Xu Y, Ceol C, Wu F, Larson A, <I>et al<\/I>.: Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150:1135-1146, 2012","DOI":"10.1016\/j.cell.2012.07.033"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T10:02:12Z","timestamp":1689328932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/54\/1\/54_67\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.54.67","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}